Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100000 participants
OBSERVATIONAL
2022-02-15
2041-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Sleep on Cardiovascular Outcomes
NCT06535178
Predictors of the Metabolic Effect of Sleep Loss
NCT00965783
Epidemiology of Sleep-Disordered Breathing in Adults
NCT00005557
Home Sleep and Metabolism
NCT02253368
Sleep Heart Health Study (SHHS) Data Coordinating Center
NCT00005275
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High risk OSA
Cohort of individuals found to sleep have scores categorized as "High risk," on the Berlin questionnaire.
No interventions assigned to this group
Low risk OSA
Cohort of individuals found to sleep have scores categorized as "Low risk," on the Berlin questionnaire.
No interventions assigned to this group
Short sleepers
Cohort of individuals found to have average sleep duration of \< 7 hours per night. Individuals who sleep on average less than 6 hours per night will further be sub-categorized as very short sleeprs.
No interventions assigned to this group
Long sleepers
Cohort of individuals found to have average sleep duration of \>9 hours per night.
No interventions assigned to this group
Average lengths leepers
Cohort of individuals found to have an average sleep duration between 7 and 9 hours per night
No interventions assigned to this group
Regular sleepers
Cohort of individuals whose standard deviation of sleep duration falls within 1 standard deviation of their mean sleep duration.
No interventions assigned to this group
Irregular sleepers
Cohort of individuals whose standard deviation of sleep duration falls greater than 1 standard deviation of their mean sleep duration
No interventions assigned to this group
Severe insomnia risk
Cohort of individuals whose scores on the Insomnia Severity Index would be categorized as severe
No interventions assigned to this group
Moderate insomnia risk
Cohort of individuals whose scores on the Insomnia Severity Index would be categorized as moderate
No interventions assigned to this group
No insomnia risk
Cohort of individuals whose scores on the Insomnia Severity Index would be categorized as low
No interventions assigned to this group
Increased social jet lag
Individuals who are more than 1 hour less or more of sleep on weekdays compared to average weekend sleep.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Residing within the United States
* Ability to use the REFRESH app on the participant's own smartphone device
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Scripps Translational Science Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stuti Jaiswal
Assistant Professor of Molecular Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stuti Jaiswal, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Scripps Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Scripps Research Institute
La Jolla, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Stuti J Jaiswal, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-21-7863
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.